Effect of Mulligan on Sub-acromial Space in Patients With Shoulder Impingement Syndrome

June 26, 2022 updated by: Al Shaymaa Shaaban Abd El Azeim, Cairo University
the aim of this study is to investigate the Effect of mulligan technique on sub-acromial space in patients with shoulder impingement syndrome

Study Overview

Status

Not yet recruiting

Detailed Description

Shoulder Impingement Syndrome (SIS) is defined as the mechanical entrapment of the rotator cuff (mainly the supraspinatus tendon) or the sub-acromial bursa in the sub-acromial space between the humeral head and the acromion or coracohumeral ligament .It is typically exacerbate when the arm is elevated or when overhead throwing activities are performed . Mulligan technique is a type of manual therapy with hypoalgesic effects, increases joint ROM, enhances muscle function and treats specific pathologies. Mobilization with movement (MWM) can be defined as the application of a sustained passive accessory force / glide to a joint while the patient actively performs a task that was previously identified as being problem.

Study Type

Interventional

Enrollment (Anticipated)

30

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt
        • Deraya university
        • Contact:
          • Noha alaa eldeen Mahmoud
          • Phone Number: 01092569170
        • Contact:
          • Amal Hassan Mohammed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

30 years to 55 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

age of patients from 30- 55 years old . Both Male and female.

Shoulder pain and two out of four specified objective signs and symptoms:

Positive Neer impingement test. Positive Hawkins-Kennedy impingement test. Painful or limitation of active shoulder elevation (flexion, abduction, scaption).

Pain or limitation with the functional movement patterns of hand-behind-back or hand-behind-head.

Exclusion Criteria:

Systemic or neurological disorder. Adhesive capsulitis. Cervical radiculopathy. History of shoulder surgery. Corticosteroid injection within the past month Subjects who had received physical therapy treatment for their shoulder within the past three months.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Group A
the patient will receive Shoulder complex mobilization with movement three time a week for two weeks
The patient will be in sitting and the therapist stands on the contralateral side of pain, stabilizing the scapula posteriorly with one hand. The head of the humerus is translated posteriorly and laterally with the other hand, along the plane of the glenoid fossa. While the glide is sustained, the patient actively elevates their arm through the plane of abduction or scaption (elevation). Apply 6-10 repetitions in a set, with 3-5 sets in a treatment session the perform mobilization on acromioclavicular and sternoclavicular joint
  1. Flexibility exercises: enhance flexibility of the glenohumeral Posterior capsule, pectoralis muscle, and upper thoracic spine.
  2. Strengthen the rotator cuff and scapular stabilizers.
  3. Improve upper-quarter postural awareness
ACTIVE_COMPARATOR: Group B
will receive Conventional therapy three times a week for two weeks.
  1. Flexibility exercises: enhance flexibility of the glenohumeral Posterior capsule, pectoralis muscle, and upper thoracic spine.
  2. Strengthen the rotator cuff and scapular stabilizers.
  3. Improve upper-quarter postural awareness

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
sub-acromial space
Time Frame: up to two weeks
sub-acromial space will be measured by ultrasonography
up to two weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
shoulder range of movement
Time Frame: up to two weeks
shoulder range of motion will be measured by digital goniometer
up to two weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
pressure pain threshold
Time Frame: up to two weeks
pressure algometer will be used to measure pressure pain threshold
up to two weeks
shoulder function
Time Frame: up to two weeks
quick DASH will be used to measure shoulder function. DASH is a shortened version of the DASH questionnaire that uses 11 items to measure the degree of difficulty in performing various physical activities due to a shoulder, arm, or hand problem (6 items); the severity of pain and tingling (2 items); and the problem's effect on social activities, work, and sleep (3 items).
up to two weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 5, 2022

Primary Completion (ANTICIPATED)

August 30, 2022

Study Completion (ANTICIPATED)

August 30, 2022

Study Registration Dates

First Submitted

June 26, 2022

First Submitted That Met QC Criteria

June 26, 2022

First Posted (ACTUAL)

June 30, 2022

Study Record Updates

Last Update Posted (ACTUAL)

June 30, 2022

Last Update Submitted That Met QC Criteria

June 26, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Shoulder Impingement

Clinical Trials on mulligan technique

3
Subscribe